SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-09-052300
Filing Date
2009-03-12
Accepted
2009-03-12 16:52:37
Documents
5
Group Members
APEX MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE TO-C dsctoc.htm SC TO-C 13160
2 JOINT PRESS RELEASE dex991.htm EX-99.1 19290
3 TRANSCRIPT OF CONFERENCE CALL dex992.htm EX-99.2 122053
4 GRAPHIC g25623ex991.jpg GRAPHIC 19074
5 GRAPHIC g25623ex99_2.jpg GRAPHIC 18335
  Complete submission text file 0001193125-09-052300.txt   208300
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94304
Business Address 3172 PORTER DR PALO ALTO CA 94304 6503848500
CV THERAPEUTICS INC (Subject) CIK: 0000921506 (see all company filings)

IRS No.: 431570294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-47551 | Film No.: 09676347
SIC: 2836 Biological Products, (No Diagnostic Substances)